| pubmed-article:11850100 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11850100 | lifeskim:mentions | umls-concept:C0011854 | lld:lifeskim |
| pubmed-article:11850100 | lifeskim:mentions | umls-concept:C1318468 | lld:lifeskim |
| pubmed-article:11850100 | lifeskim:mentions | umls-concept:C0005198 | lld:lifeskim |
| pubmed-article:11850100 | lifeskim:mentions | umls-concept:C1414925 | lld:lifeskim |
| pubmed-article:11850100 | lifeskim:mentions | umls-concept:C0039725 | lld:lifeskim |
| pubmed-article:11850100 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11850100 | pubmed:dateCreated | 2002-2-18 | lld:pubmed |
| pubmed-article:11850100 | pubmed:abstractText | We measured the cell-mediated immune response to GAD and bovine beta-casein in 38 type 1 and 37 type 2 diabetic patients who visited diabetic clinics or who were hospitalized in Bangkok, Thailand, and in 43 normal controls, by using a lymphoproliferation assay. Positive results against GAD were found in 29/38 (76.3%) type 1, 6/37 (16.2%) type 2 diabetic patients and 1/43 (2.3%) normal controls. Positive results against bovine beta-casein were found in 18/38 (47.4%), 5/37 (13.5%) and 1/43 (2.3%) of these subjects, respectively. The frequencies of the positive results and the magnitude of the responses to both antigens in type 1 diabetic patients were significantly higher than those in the other two groups (P<0.001). In addition, the prevalence of a positive lymphoproliferative response to these antigens in type 1 diabetic patients was higher than that of anti-GAD antibody positivity in the same group of subjects (26.3%). Thus, the prevalence of positive lymphoproliferative response to GAD in type 1 diabetic patients studied was higher than the prevalence of other autoimmune markers previously reported in type 1 diabetic patients in Thailand. | lld:pubmed |
| pubmed-article:11850100 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11850100 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11850100 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11850100 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11850100 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11850100 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11850100 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11850100 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11850100 | pubmed:issn | 0168-8227 | lld:pubmed |
| pubmed-article:11850100 | pubmed:author | pubmed-author:PloybutrSirir... | lld:pubmed |
| pubmed-article:11850100 | pubmed:author | pubmed-author:BanchuinNapat... | lld:pubmed |
| pubmed-article:11850100 | pubmed:author | pubmed-author:Boonyasrisawa... | lld:pubmed |
| pubmed-article:11850100 | pubmed:author | pubmed-author:VannasaengSat... | lld:pubmed |
| pubmed-article:11850100 | pubmed:author | pubmed-author:Deerochanawon... | lld:pubmed |
| pubmed-article:11850100 | pubmed:author | pubmed-author:Sriussadaporn... | lld:pubmed |
| pubmed-article:11850100 | pubmed:author | pubmed-author:PasurakulThaw... | lld:pubmed |
| pubmed-article:11850100 | pubmed:author | pubmed-author:Yenchitsomanu... | lld:pubmed |
| pubmed-article:11850100 | pubmed:author | pubmed-author:DharakulTarar... | lld:pubmed |
| pubmed-article:11850100 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11850100 | pubmed:volume | 55 | lld:pubmed |
| pubmed-article:11850100 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11850100 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11850100 | pubmed:pagination | 237-45 | lld:pubmed |
| pubmed-article:11850100 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:meshHeading | pubmed-meshheading:11850100... | lld:pubmed |
| pubmed-article:11850100 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11850100 | pubmed:articleTitle | Cell-mediated immune responses to GAD and beta-casein in type 1 diabetes mellitus in Thailand. | lld:pubmed |
| pubmed-article:11850100 | pubmed:affiliation | Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. sinbc@mahidol.ac.th | lld:pubmed |
| pubmed-article:11850100 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11850100 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11850100 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
